Recognition of immunogenomic signature and prognostic value of the subtype of epithelial-mesenchymal transition in breast cancer
Open Access
- 19 January 2026
- journal article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 45, 102456
Abstract
No abstract availableKeywords
Funding Information
- Jiangsu Commission of Health
- Jiangsu Provincial Health Commission (MQ2024036)
This publication has 40 references indexed in Scilit:
- EMT-induced immune evasion: connecting the dots from mechanisms to therapyClinical and Experimental Medicine, 2023
- Mechanism of epithelial‐mesenchymal transition in cancer and its regulation by natural compoundsMedicinal Research Reviews, 2023
- Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistanceDrug Resistance Updates, 2020
- Hypoxia, partial EMT and collective migration: Emerging culprits in metastasisTranslational Oncology, 2020
- EMT, MET, Plasticity, and Tumor MetastasisTrends in Cell Biology, 2020
- Histidine-rich glycoprotein (HRGP): Pleiotropic and paradoxical effects on macrophage, tumor microenvironment, angiogenesis, and other physiological and pathological processesGenes & Diseases, 2020
- An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T CellsCell, 2020
- Identification and validation of a combined hypoxia and immune index for triple‐negative breast cancerMolecular Oncology, 2020
- Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targetsSeminars in Cancer Biology, 2020
- Communication between EMT and PD-L1 signaling: New insights into tumor immune evasionCancer Letters, 2020